← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Chromatan Corporation
Dedham, MA
$8,029,352
Total funding
4
Grants
Funding over time
peak $1.5M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,029,352 · 4
By mechanism
R44$7,846,352 · 3
R43$183,000 · 1
Investigators at Chromatan Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Resubmission - Development and scale-up of Continuous Countercurrent Tangential Chromatography (CCTC) for next generation AAV vector manufacturing (Direct to Phase II)$1,304,417
R44 · FY2024 · GM
Continuation Application for the development of Integrated continuous and single-use (ICS) bioproduction platform (Phase IIB)$1,284,233
R44 · FY2022 · GM
Commercialization of Integrated Continuous and Single-use Bio-production Capture Platform (ICS)$941,104
R44 · FY2017 · GM
Continuation Application for the development of Integrated continuous and single-use (ICS) bioproduction platform (Phase IIB)$707,318
R44 · FY2023 · GM
Resubmission - Development and scale-up of Continuous Countercurrent Tangential Chromatography (CCTC) for next generation AAV vector manufacturing (Direct to Phase II)$695,448
R44 · FY2025 · GM
Phase II Commercialization of Continuous Countercurrent Tangential Chromatography$595,076
R44 · FY2013 · GM
Commercialization of Integrated Continuous and Single-use Bio-production Capture Platform (ICS)$540,290
R44 · FY2018 · GM
Continuation Application for the development of Integrated continuous and single-use (ICS) bioproduction platform (Phase IIB)$503,755
R44 · FY2023 · GM
Phase II Commercialization of Continuous Countercurrent Tangential Chromatography$407,095
R44 · FY2014 · GM
Commercialization of Integrated Continuous and Single-use Bio-production Capture Platform (ICS)$255,778
R44 · FY2018 · GM
Commercialization of Integrated Continuous and Single-use Bio-production Capture Platform (ICS)$222,379
R44 · FY2016 · GM
Resubmission - Development and scale-up of Continuous Countercurrent Tangential Chromatography (CCTC) for next generation AAV vector manufacturing (Direct to Phase II)$214,459
R44 · FY2024 · GM
Continuous Countercurrent Tangential Chromatography$183,000
R43 · FY2011 · RR
Phase II Commercialization of Continuous Countercurrent Tangential Chromatography$175,000
R44 · FY2014 · GM